propranolol has been researched along with natriuretic peptide, brain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bidzseranova, A; Telegdy, G; Várga, J | 1 |
| Bidzseranova, A; Gueron, J; Telegdy, G; Varga, J | 1 |
| Chiba, S; Furukawa, Y; Hirose, M; Kurogouchi, F; Miyashita, Y; Nakajima, K | 1 |
| Burnett , JC; Grande, JP; Hart, CY; Housmans, PR; Meyer, DM; Redfield, MM; Tazelaar, HD | 1 |
5 other study(ies) available for propranolol and natriuretic peptide, brain
| Article | Year |
|---|---|
The effects of receptor blockers on brain natriuretic peptide-32-induced action on passive avoidance behavior in rats.
Topics: Animals; Atropine; Avoidance Learning; Brain; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Male; Naloxone; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Propranolol; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter | 1992 |
Effects of brain natriuretic peptide-32 on the extinction of active avoidance behavior in rats. Transmitter-mediated action.
Topics: Animals; Atropine; Avoidance Learning; Extinction, Psychological; Haloperidol; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Neurotransmitter Agents; Phenoxybenzamine; Propranolol; Rats; Rats, Inbred Strains | 1992 |
C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cyclic AMP; Cyclic GMP; Dogs; Guanylate Cyclase; Heart Rate; Myocardial Contraction; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Nitroprusside; Perfusion; Polysaccharides; Propranolol; Proteins; Receptors, Atrial Natriuretic Factor; Sinoatrial Node | 1998 |
Load versus humoral activation in the genesis of early hypertensive heart disease.
Topics: Angiotensin II; Animals; Catecholamines; Diastole; Disease Models, Animal; Dogs; Endothelin-1; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Natriuretic Peptide, Brain; Propranolol; Renin; Systole; Ventricular Dysfunction, Left | 2001 |
Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation.
Topics: Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Drug Repositioning; Echocardiography; Gene Expression Regulation; Heart Valves; Heterozygote; Humans; Infant; MAP Kinase Kinase 1; Mutation; Natriuretic Peptide, Brain; Noonan Syndrome; Peptide Fragments; Propranolol; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; ras Proteins; Signal Transduction; Treatment Outcome | 2019 |